Short-Acting Insulin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on short-acting insulin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for short-acting insulin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The short-acting insulin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Formulation: Regular Insulin; Rapid-Acting Insulin
2) By Dosage Form: Vials; Pre-filled Pens; Cartridges
3) By Route Of Administration: Subcutaneous; Intravenous
4) By Patient Type: Type 1 Diabetes; Type 2 Diabetes
5) By Distribution Channel: Pharmacies; Hospital Pharmacies; Online Pharmacies
Subsegments:
1) By Regular Insulin: Human Regular Insulin; Animal-Derived Regular Insulin; Other Regular Insulin
2) By Rapid-Acting Insulin: Insulin Lispro; Insulin Aspart; Insulin Glulisine
Companies Mentioned: Sanofi S.A.; Eli Lilly and Company; Novo Nordisk A/S; Baxter International Inc.; Eisai Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
- 1. Executive Summary
- 2. Short-Acting Insulin Market Characteristics
- 3. Short-Acting Insulin Market Trends And Strategies
- 4. Short-Acting Insulin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Short-Acting Insulin Growth Analysis And Strategic Analysis Framework
- 5.1. Global Short-Acting Insulin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Short-Acting Insulin Market Growth Rate Analysis
- 5.4. Global Short-Acting Insulin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Short-Acting Insulin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Short-Acting Insulin Total Addressable Market (TAM)
- 6. Short-Acting Insulin Market Segmentation
- 6.1. Global Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Regular Insulin
- Rapid-Acting Insulin
- 6.2. Global Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Vials
- Pre-filled Pens
- Cartridges
- 6.3. Global Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Subcutaneous
- Intravenous
- 6.4. Global Short-Acting Insulin Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Type 1 Diabetes
- Type 2 Diabetes
- 6.5. Global Short-Acting Insulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- 6.6. Global Short-Acting Insulin Market, Sub-Segmentation Of Regular Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Human Regular Insulin
- Animal-Derived Regular Insulin
- Other Regular Insulin
- 6.7. Global Short-Acting Insulin Market, Sub-Segmentation Of Rapid-Acting Insulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Insulin Lispro
- Insulin Aspart
- Insulin Glulisine
- 7. Short-Acting Insulin Market Regional And Country Analysis
- 7.1. Global Short-Acting Insulin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Short-Acting Insulin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Short-Acting Insulin Market
- 8.1. Asia-Pacific Short-Acting Insulin Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Short-Acting Insulin Market
- 9.1. China Short-Acting Insulin Market Overview
- 9.2. China Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Short-Acting Insulin Market
- 10.1. India Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Short-Acting Insulin Market
- 11.1. Japan Short-Acting Insulin Market Overview
- 11.2. Japan Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Short-Acting Insulin Market
- 12.1. Australia Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Short-Acting Insulin Market
- 13.1. Indonesia Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Short-Acting Insulin Market
- 14.1. South Korea Short-Acting Insulin Market Overview
- 14.2. South Korea Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Short-Acting Insulin Market
- 15.1. Western Europe Short-Acting Insulin Market Overview
- 15.2. Western Europe Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Short-Acting Insulin Market
- 16.1. UK Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Short-Acting Insulin Market
- 17.1. Germany Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Short-Acting Insulin Market
- 18.1. France Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Short-Acting Insulin Market
- 19.1. Italy Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Short-Acting Insulin Market
- 20.1. Spain Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Short-Acting Insulin Market
- 21.1. Eastern Europe Short-Acting Insulin Market Overview
- 21.2. Eastern Europe Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Short-Acting Insulin Market
- 22.1. Russia Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Short-Acting Insulin Market
- 23.1. North America Short-Acting Insulin Market Overview
- 23.2. North America Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Short-Acting Insulin Market
- 24.1. USA Short-Acting Insulin Market Overview
- 24.2. USA Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Short-Acting Insulin Market
- 25.1. Canada Short-Acting Insulin Market Overview
- 25.2. Canada Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Short-Acting Insulin Market
- 26.1. South America Short-Acting Insulin Market Overview
- 26.2. South America Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Short-Acting Insulin Market
- 27.1. Brazil Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Short-Acting Insulin Market
- 28.1. Middle East Short-Acting Insulin Market Overview
- 28.2. Middle East Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Short-Acting Insulin Market
- 29.1. Africa Short-Acting Insulin Market Overview
- 29.2. Africa Short-Acting Insulin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Short-Acting Insulin Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Short-Acting Insulin Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Short-Acting Insulin Market Competitive Landscape And Company Profiles
- 30.1. Short-Acting Insulin Market Competitive Landscape
- 30.2. Short-Acting Insulin Market Company Profiles
- 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 31. Short-Acting Insulin Market Other Major And Innovative Companies
- 31.1. Sumitomo Pharma Co. Ltd.
- 31.2. Biocon Limited
- 31.3. Kissei Pharmaceutical Co. Ltd.
- 31.4. Lupin Limited
- 31.5. Wockhardt Ltd.
- 31.6. Lannett Co. Inc.
- 31.7. MannKind Corporation
- 31.8. Sihuan Pharmaceutical Holdings Group Ltd.
- 31.9. Julphar(Gulf Pharmaceutical Industries)
- 31.10. Geropharm LLC
- 31.11. Bioton S.A.
- 31.12. hec pharm co. ltd
- 31.13. ADOCIA SAS
- 31.14. Gan & Lee Pharmaceuticals Co. Ltd.
- 31.15. Adocia S.A.S.
- 32. Global Short-Acting Insulin Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Short-Acting Insulin Market
- 34. Recent Developments In The Short-Acting Insulin Market
- 35. Short-Acting Insulin Market High Potential Countries, Segments and Strategies
- 35.1 Short-Acting Insulin Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Short-Acting Insulin Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Short-Acting Insulin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook